Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · IEX Real-Time Price · USD
1.12
+0.01 (0.90%)
At close: Jun 24, 2022 4:00 PM
1.10
-0.02 (-1.79%)
After-hours:
Jun 24, 2022 7:59 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
|
Revenue
|
0.27 | 1.07 | 1.71 | 3.51 | 1.73 | 2.57 | 0.59 |
|
Revenue Growth (YoY)
|
-74.93% | -37.41% | -51.28% | 103.25% | -32.88% | 335.59% | - |
|
Gross Profit
|
0.27 | 1.07 | 1.71 | 3.51 | 1.73 | 2.57 | 0.59 |
|
Selling, General & Admin
|
8.54 | 7.92 | 7.23 | 6.59 | 5.42 | 4.47 | 2.49 |
|
Research & Development
|
48.45 | 16.35 | 19.33 | 33.65 | 19.08 | 20.27 | 11.32 |
|
Operating Expenses
|
56.99 | 24.27 | 26.56 | 40.25 | 24.5 | 24.73 | 13.81 |
|
Operating Income
|
-56.72 | -23.2 | -24.85 | -36.74 | -22.78 | -22.16 | -13.22 |
|
Interest Expense / Income
|
0 | 0 | 0 | 0 | 0 | 0.34 | 0.24 |
|
Other Expense / Income
|
-0.05 | -0.12 | -0.14 | -0.37 | -0.1 | -0.05 | 0.44 |
|
Pretax Income
|
-56.67 | -23.08 | -24.71 | -36.37 | -22.68 | -22.46 | -13.89 |
|
Net Income
|
-56.67 | -23.08 | -24.71 | -36.37 | -22.68 | -22.46 | -13.89 |
|
Net Income Common
|
-56.67 | -23.08 | -24.71 | -36.37 | -22.68 | -22.46 | -13.89 |
|
Shares Outstanding (Basic)
|
76 | 56 | 35 | 29 | 23 | 22 | 10 |
|
Shares Outstanding (Diluted)
|
76 | 56 | 35 | 29 | 23 | 22 | 10 |
|
Shares Change
|
36.18% | 58.14% | 23.64% | 26.24% | 4.99% | 118.60% | - |
|
EPS (Basic)
|
-0.75 | -0.41 | -0.70 | -1.27 | -1.00 | -1.04 | -1.41 |
|
EPS (Diluted)
|
-0.75 | -0.41 | -0.70 | -1.27 | -1.00 | -1.04 | -1.41 |
|
Free Cash Flow Per Share
|
-0.35 | -0.30 | -0.60 | -0.90 | -0.68 | -0.46 | -0.11 |
|
Gross Margin
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
|
Operating Margin
|
-21165.30% | -2170.35% | -1454.92% | -1047.92% | -1320.29% | -862.41% | -2240.85% |
|
Profit Margin
|
-21145.52% | -2159.12% | -1446.96% | -1037.28% | -1314.61% | -873.97% | -2354.58% |
|
Free Cash Flow Margin
|
-9815.67% | -1548.27% | -1251.35% | -736.02% | -896.29% | -387.16% | -187.80% |
|
EBITDA
|
-56.67 | -23.08 | -24.71 | -36.37 | -22.68 | -22.12 | -13.66 |
|
EBITDA Margin
|
-21145.52% | -2159.12% | -1446.96% | -1037.28% | -1314.61% | -860.58% | -2314.75% |
|
EBIT
|
-56.67 | -23.08 | -24.71 | -36.37 | -22.68 | -22.12 | -13.66 |
|
EBIT Margin
|
-21145.52% | -2159.12% | -1446.96% | -1037.28% | -1314.61% | -860.58% | -2314.75% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).